Solventum Co. (NYSE:SOLV) Receives $79.86 Consensus Target Price from Analysts

Solventum Co. (NYSE:SOLV - Get Free Report) has been assigned an average rating of "Hold" from the ten analysts that are currently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, eight have issued a hold recommendation and one has assigned a buy recommendation to the company. The average 1-year price target among brokers that have covered the stock in the last year is $79.86.

SOLV has been the subject of a number of research reports. Bank of America raised their target price on shares of Solventum from $80.00 to $85.00 and gave the stock a "neutral" rating in a research note on Wednesday, February 26th. Morgan Stanley upped their price target on shares of Solventum from $73.00 to $80.00 and gave the company an "equal weight" rating in a research note on Wednesday, March 5th. The Goldman Sachs Group lifted their price objective on shares of Solventum from $63.00 to $71.00 and gave the stock a "sell" rating in a research note on Monday, March 3rd. Mizuho raised their target price on shares of Solventum from $70.00 to $82.00 and gave the stock a "neutral" rating in a report on Monday, March 3rd. Finally, Wells Fargo & Company boosted their price target on Solventum from $73.00 to $75.00 and gave the company an "equal weight" rating in a research note on Friday, February 28th.

Institutional Trading of Solventum

Several hedge funds have recently made changes to their positions in SOLV. MML Investors Services LLC increased its holdings in Solventum by 3.2% during the 3rd quarter. MML Investors Services LLC now owns 5,345 shares of the company's stock worth $373,000 after acquiring an additional 168 shares during the period. Virtu Financial LLC bought a new position in shares of Solventum during the 3rd quarter valued at $568,000. Sanctuary Advisors LLC raised its position in Solventum by 95.6% in the 3rd quarter. Sanctuary Advisors LLC now owns 19,074 shares of the company's stock worth $1,351,000 after purchasing an additional 9,323 shares during the period. Wilmington Savings Fund Society FSB lifted its stake in Solventum by 196.7% in the third quarter. Wilmington Savings Fund Society FSB now owns 17,062 shares of the company's stock worth $1,190,000 after purchasing an additional 11,312 shares during the last quarter. Finally, Principal Financial Group Inc. boosted its position in Solventum by 3.0% during the third quarter. Principal Financial Group Inc. now owns 169,615 shares of the company's stock valued at $11,826,000 after buying an additional 4,896 shares during the period.

Solventum Stock Up 1.0 %

Shares of Solventum stock traded up $0.65 on Friday, reaching $66.55. 38,233 shares of the company were exchanged, compared to its average volume of 1,308,622. Solventum has a one year low of $47.16 and a one year high of $85.92. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45. The company has a 50-day moving average of $72.87 and a 200 day moving average of $71.56. The company has a market capitalization of $11.51 billion and a price-to-earnings ratio of 24.20.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.